The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary population pharmacokinetics supports phase II dose selection for masked anti-PD-L1 antibody CX-072.
 
Mark Stroh
Employment - CytomX Therapeutics
Stock and Other Ownership Interests - CytomX Therapeutics
Travel, Accommodations, Expenses - CytomX Therapeutics
 
Michelle Green
Employment - Certara Inc
Stock and Other Ownership Interests - Abbvie
Travel, Accommodations, Expenses - Certara Inc
 
Bjorn L. Millard
Employment - Applied BioMath
 
William Garner
Employment - CytomX Therapeutics; Gilead Sciences; Kite/Gilead (I); MyoKardia (I)
Stock and Other Ownership Interests - CytomX Therapeutics; Gilead Sciences; Gilead Sciences (I); MyoKardia (I)
 
Hong Lu
No Relationships to Disclose
 
Jennifer Hope Richardson
Employment - CytomX Therapeutics
Stock and Other Ownership Interests - CytomX Therapeutics
Research Funding - CytomX Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Patents (Inst)
Travel, Accommodations, Expenses - CytomX Therapeutics
 
Alison L. Hannah
Leadership - NeoGenomics Laboratories
Stock and Other Ownership Interests - NeoGenomics Laboratories
Consulting or Advisory Role - Basilea; Nektar; Pfizer